扶桑薬品工業(株)の貸借残高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4538/E00953Fuso Pharmaceutical Industries, Ltd.
公表日公表担保貸付残高前週比借入残高(自己)前週比借入残高(転貸)前週比
2024/01/12日証協無担保11,600株0.00%0株0.00%56,818株0.00%
2024/01/12日証協有担保166,401株0.00%157,891株0.00%90,832株0.00%
2024/01/05日証協無担保12,000株0.00%0株0.00%59,627株0.00%
2024/01/05日証協有担保180,395株0.00%157,991株0.00%103,060株0.00%
2023/12/29日証協無担保12,000株0.00%0株0.00%51,625株0.00%
2023/12/29日証協有担保186,411株0.00%158,491株0.00%109,832株0.00%
2023/12/22日証協無担保11,900株0.00%0株0.00%61,431株0.00%
2023/12/22日証協有担保214,129株0.00%155,891株0.00%139,460株0.00%
2023/12/15日証協無担保11,200株0.00%0株0.00%61,530株0.00%
2023/12/15日証協有担保181,922株0.00%189,407株0.00%113,044株0.00%
2023/12/08日証協無担保10,200株0.00%0株0.00%58,217株0.00%
2023/12/08日証協有担保172,512株0.00%80,007株0.00%102,244株0.00%
2023/12/01日証協無担保9,000株0.00%0株0.00%56,916株0.00%
2023/12/01日証協有担保169,823株0.00%78,807株0.00%101,444株0.00%
2023/11/24日証協無担保8,700株0.00%0株0.00%90,214株0.00%
2023/11/24日証協有担保168,578株0.00%78,206株0.00%97,643株0.00%
2023/11/17日証協無担保8,800株0.00%0株0.00%88,113株0.00%
2023/11/17日証協有担保166,978株0.00%77,806株0.00%95,743株0.00%
2023/11/10日証協無担保8,200株0.00%0株0.00%86,703株0.00%
2023/11/10日証協有担保147,178株0.00%71,806株0.00%78,943株0.00%
2023/11/02日証協無担保8,700株0.00%0株0.00%81,003株0.00%
2023/11/02日証協有担保132,778株0.00%62,507株0.00%67,943株0.00%
2023/10/27日証協無担保8,400株0.00%0株0.00%81,203株0.00%
2023/10/27日証協有担保94,844株0.00%46,953株0.00%53,109株0.00%
2023/10/20日証協無担保9,900株0.00%0株0.00%80,603株0.00%
2023/10/20日証協有担保84,623株0.00%38,553株0.00%48,283株0.00%
2023/10/13日証協無担保9,200株0.00%0株0.00%77,993株0.00%
2023/10/13日証協有担保85,240株0.00%35,053株0.00%53,009株0.00%
2023/10/06日証協無担保8,900株0.00%0株0.00%75,693株0.00%
2023/10/06日証協有担保91,640株0.00%32,753株0.00%58,200株0.00%
2023/09/29日証協無担保2,700株0.00%0株0.00%14,234株0.00%
2023/09/29日証協有担保42,240株0.00%31,653株0.00%9,600株0.00%
2023/09/22日証協無担保0株0.00%6,700株0.00%63,195株0.00%
2023/09/22日証協有担保4,340株0.00%40,653株0.00%10,200株0.00%
2023/09/15日証協無担保0株0.00%0株0.00%59,981株0.00%
2023/09/15日証協有担保41,540株0.00%34,453株0.00%19,184株0.00%
2023/09/08日証協無担保0株0.00%100株0.00%51,169株0.00%
2023/09/08日証協有担保7,274株0.00%35,953株0.00%7,234株0.00%

※株式分割は考慮していませんのでご注意ください。

Page Top